Acrolein antibody

Catalog No. ABIN335409

This anti-Acrolein antibody is a Mouse Monoclonal antibody detecting Acrolein in IHC. Suitable for . This Primary Antibody has been cited in 1 publication.

Quick Overview for Acrolein antibody (ABIN335409)

Target: Acrolein (ACR)

Host: Mouse

Clonality: Monoclonal

Conjugate: This Acrolein antibody is un-conjugated

Application: Immunohistochemistry (IHC)

Clone: F56

Product Details anti-Acrolein Antibody

Specificity: Specific for ACR-modified protein (especially FDP-lysine type derivative)

Immunogen: ACR-modified keyhole-lympet hemocyanine

Isotype: IgG1

Application Details

Application Notes: IHC: Recommended antibody concentration is 0.5-1.0 micro gram/mL on paraformaldehyde fixed tissue.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Frozen (100 micro g/mL antibody in 10mM PBS containing 0.1% NaN3 and 0.5% BSA). Purified by Protein-A.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

References for anti-Acrolein antibody (ABIN335409)

Sugiyama, Sun, Nishinohara, Fujita, Masuda, Ochi, Takeuchi: "Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats." in: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 73, Issue 6, pp. 821-6, (2011) (PubMed).

Target Details for Acrolein

Target: Acrolein (ACR)

Target Type: Chemical

Background: Acrolein (ACR) is a representative carcinogenic aldehyde found ubiquitously in the environment and formed endogenously through oxidation reactions, such as lipid peroxidation and myeloperoxidasecatalyzed amino acid oxidation. This antibody is specific for the ACR-modified protein, especially FDP-lysine type derivative.